We strive to cultivate relationships with healthcare investors, sell-side analysts, and business development professionals through:
Investors, analysts &
strategics in our network
Chance of research reports
from covering analysts
Sr. Manager, Marketing
& Brand Strategy
“LifeSci has been instrumental and has successfully executed our annual R&D Day for several years, connecting KOLs with specialized biotech investors.”
Founder, President, CEO – Y-mAbs Therapeutics
From all of the advance planning to the pre-recordings to the live virtual event, we were very pleased with the level of execution and professionalism.
Vice President, Investor Relations & Corporate Communications – Axcella Health
I think I can speak for us in IR and say that out of the calls we had yesterday, this was certainly the best one. It was an enjoyable event with thoughtful questions to foster a better understanding of Johnson & Johnson’s business.
Executive Vice President and Chief Financial Ofﬁcer – Johnson & Johnson
LifeSci was instrumental in helping Enterin prepare for our KOL call to discuss top line results of our Phase 2 clinical trial. We were very satisfied with the outcome and received much positive feedback post call.
Chief Financial Officer – Enterin
You were exceptionally professional and were a great source of calm and expertise as I navigated the process from the Angion side. MUCH appreciated.